Towards the eradication of HPV infection through universal specific vaccination

Piergiorgio Crosignani, Antonella De Stefani, Gaetano Maria Fara, Andrea M. Isidori, Andrea Lenzi, Carlo Antonio Liverani, Alberto Lombardi, Francesco Saverio Mennini, Giorgio Palu', Sergio Pecorelli, Andrea P. Peracino, Carlo Signorelli, Gian Vincenzo Zuccotti

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies. Discussion. A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations' intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men. Summary. The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.

Original languageEnglish
Article number642
JournalBMC Public Health
Volume13
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Papillomavirus Infections
Vaccination
Uterine Cervical Neoplasms
Economics
Pharyngeal Neoplasms
Medical Economics
Papillomavirus Vaccines
Immunization Programs
Program Evaluation
Natural History
Molecular Biology
Epidemiology
Organizations
Delivery of Health Care

Keywords

  • Anti-HPV vaccines
  • Cervical cancer
  • Condylomas
  • Genital cancer
  • HPV infection
  • Incremental cost-effectiveness ratio
  • Oro-pharyngeal cancer
  • Universal vaccination
  • Vaccination programs

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Crosignani, P., De Stefani, A., Fara, G. M., Isidori, A. M., Lenzi, A., Liverani, C. A., ... Zuccotti, G. V. (2013). Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health, 13(1), [642]. https://doi.org/10.1186/1471-2458-13-642

Towards the eradication of HPV infection through universal specific vaccination. / Crosignani, Piergiorgio; De Stefani, Antonella; Fara, Gaetano Maria; Isidori, Andrea M.; Lenzi, Andrea; Liverani, Carlo Antonio; Lombardi, Alberto; Mennini, Francesco Saverio; Palu', Giorgio; Pecorelli, Sergio; Peracino, Andrea P.; Signorelli, Carlo; Zuccotti, Gian Vincenzo.

In: BMC Public Health, Vol. 13, No. 1, 642, 2013.

Research output: Contribution to journalArticle

Crosignani, P, De Stefani, A, Fara, GM, Isidori, AM, Lenzi, A, Liverani, CA, Lombardi, A, Mennini, FS, Palu', G, Pecorelli, S, Peracino, AP, Signorelli, C & Zuccotti, GV 2013, 'Towards the eradication of HPV infection through universal specific vaccination', BMC Public Health, vol. 13, no. 1, 642. https://doi.org/10.1186/1471-2458-13-642
Crosignani, Piergiorgio ; De Stefani, Antonella ; Fara, Gaetano Maria ; Isidori, Andrea M. ; Lenzi, Andrea ; Liverani, Carlo Antonio ; Lombardi, Alberto ; Mennini, Francesco Saverio ; Palu', Giorgio ; Pecorelli, Sergio ; Peracino, Andrea P. ; Signorelli, Carlo ; Zuccotti, Gian Vincenzo. / Towards the eradication of HPV infection through universal specific vaccination. In: BMC Public Health. 2013 ; Vol. 13, No. 1.
@article{89b730dd9f2647b5bab5219657736f17,
title = "Towards the eradication of HPV infection through universal specific vaccination",
abstract = "Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies. Discussion. A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations' intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men. Summary. The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.",
keywords = "Anti-HPV vaccines, Cervical cancer, Condylomas, Genital cancer, HPV infection, Incremental cost-effectiveness ratio, Oro-pharyngeal cancer, Universal vaccination, Vaccination programs",
author = "Piergiorgio Crosignani and {De Stefani}, Antonella and Fara, {Gaetano Maria} and Isidori, {Andrea M.} and Andrea Lenzi and Liverani, {Carlo Antonio} and Alberto Lombardi and Mennini, {Francesco Saverio} and Giorgio Palu' and Sergio Pecorelli and Peracino, {Andrea P.} and Carlo Signorelli and Zuccotti, {Gian Vincenzo}",
year = "2013",
doi = "10.1186/1471-2458-13-642",
language = "English",
volume = "13",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Towards the eradication of HPV infection through universal specific vaccination

AU - Crosignani, Piergiorgio

AU - De Stefani, Antonella

AU - Fara, Gaetano Maria

AU - Isidori, Andrea M.

AU - Lenzi, Andrea

AU - Liverani, Carlo Antonio

AU - Lombardi, Alberto

AU - Mennini, Francesco Saverio

AU - Palu', Giorgio

AU - Pecorelli, Sergio

AU - Peracino, Andrea P.

AU - Signorelli, Carlo

AU - Zuccotti, Gian Vincenzo

PY - 2013

Y1 - 2013

N2 - Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies. Discussion. A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations' intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men. Summary. The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.

AB - Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies. Discussion. A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations' intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men. Summary. The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.

KW - Anti-HPV vaccines

KW - Cervical cancer

KW - Condylomas

KW - Genital cancer

KW - HPV infection

KW - Incremental cost-effectiveness ratio

KW - Oro-pharyngeal cancer

KW - Universal vaccination

KW - Vaccination programs

UR - http://www.scopus.com/inward/record.url?scp=84880023249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880023249&partnerID=8YFLogxK

U2 - 10.1186/1471-2458-13-642

DO - 10.1186/1471-2458-13-642

M3 - Article

C2 - 23845195

AN - SCOPUS:84880023249

VL - 13

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

M1 - 642

ER -